Find permanent physician & healthcare provider jobs

Hematology involves the study and treatment of blood and bone-marrow disorders, such as anemia, clotting disorders, hemophilia, and benign hematologic conditions. Blood is composed of different parts, including blood cells, plasma, and platelets, each playing a crucial role in overall health. Blood transports oxygen to organs throughout the body, making blood health essential for proper organ function. Oncology focuses on the diagnosis and treatment of cancer, including chemotherapy, immunotherapy, radiation collaboration, surgical coordination, and survivorship.

Hematologist-oncologists integrate these domains to manage conditions like leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, and solid-tumor malignancies. They use diagnostics (e.g., bone-marrow biopsy, flow cytometry, PET/CT imaging), and tests often evaluate platelets and coagulation to assess blood health. Blood tests can also measure chemicals to help diagnose illnesses or monitor health conditions.

Practitioners may specialize in different areas within hematology, focusing on specific diseases or patient populations. They design treatment plans, oversee infusions and targeted therapies, and coordinate long-term follow-up and palliative care. The evolving landscape of precision medicine, immunotherapy, and survivorship care is driving growth in the need for specialist physicians and the variety of oncologist jobs across these fields.

Blood cancers, also known as hematologic cancers, are a group of diseases that originate in the blood, bone marrow, or lymphatic system. These cancers disrupt the normal production and function of blood cells, which can impact the immune system, oxygen delivery, and the body’s ability to fight infections or control bleeding. Understanding the different types of blood cancers is essential for developing effective treatment plans and improving patient outcomes in the field of hematology-oncology.

The three main types of blood cancers are leukemia, lymphoma, and multiple myeloma:

• Leukemia is a blood cancer that begins in the bone marrow and leads to the uncontrolled production of abnormal white blood cells. This overproduction can crowd out healthy blood cells, causing symptoms such as anemia, frequent infections, and easy bruising or bleeding. Leukemia is diagnosed through blood tests, bone marrow biopsies, and other specialized tests that evaluate the number and type of blood cells present.
• Lymphoma affects the lymphatic system, a crucial part of the immune system. This cancer causes an abnormal increase in lymphocytes, a type of white blood cell that helps protect the body from infection. Lymphoma can be classified into Hodgkin and non-Hodgkin types, each requiring specific tests and treatment approaches. Symptoms may include swollen lymph nodes, fever, night sweats, and unexplained weight loss.
• Multiple Myeloma is a cancer of the plasma cells, another type of white blood cell found in the bone marrow. In multiple myeloma, abnormal plasma cells multiply and produce harmful proteins, which can damage bones, kidneys, and the immune system. Diagnosis often involves blood tests, urine tests, bone marrow biopsies, and imaging studies to assess the extent of disease.

Treatment for blood cancers is highly individualized and may include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies designed to attack specific cancer cells. Hematologists and oncologists work closely together to review test results, decide on the best treatment plan, and refer patients to specialized care teams when needed. Stem cell transplantation, for example, is often performed for certain types of leukemia, lymphoma, or multiple myeloma, offering hope for long-term remission.

Ongoing research in hematology-oncology is focused on understanding the underlying causes of blood cancers and developing new targeted therapies and immunotherapies. Patients with blood cancers often require comprehensive care to manage symptoms, side effects, and related health concerns. A multidisciplinary care team—including hematologists, oncologists, nurses, pharmacists, and supportive care specialists—works together to provide complete, patient-centered services throughout the course of treatment.

By staying at the forefront of research and clinical practice, hematology-oncology professionals continue to improve the outlook for patients with blood cancers, offering new hope and innovative treatment options in this challenging and rewarding field.

Physicians pursuing hematology-oncology roles can explore a variety of settings and subspecialty paths, with different areas of focus:

• General Hematologist-Oncologist: Managing a full spectrum of blood and cancer disorders, including non cancerous blood conditions, in outpatient and inpatient settings. Focusing on a specific disorder or patient population can be especially appealing for those who want to develop targeted expertise.
• Hematologic Malignancy Specialist: Focusing on leukemia, lymphoma, myeloma, stem-cell transplantation, and cellular therapies.
• Solid-Tumor Oncologist: Specializing in cancers such as breast, lung, GI, GU, melanoma, or head & neck.
• Pediatric Hematology/Oncology: A separate pediatric subspecialty pathway providing care for infants, children, and adolescents with malignant and nonmalignant hematologic disorders and cancer.
• Hematopoietic Cell Transplantation (HCT) and Cellular Therapy: Providing specialized care involving autologous and allogeneic transplantation, CAR-T therapy, and other cellular therapies.
• Clinical Research & Academic Hematology/Oncology: Conducting clinical trials, publishing scientific research, and teaching fellows/residents.
• Leadership/Program Director Roles: Directing hematology/oncology services, establishing cancer programs, or leading survivorship initiatives.

These career tracks allow physicians to choose practice models that align with their interests — whether procedural, academic, clinical-practice, or research-focused — and to pursue hematology-oncology jobs in major medical centers, cancer institutes, academic hospitals, or community practices. Physicians often select their subspecialty based on their personal interest in specific areas of hematology or oncology, which can guide their career development and satisfaction.

Hematologist-oncologists deliver comprehensive, patient-centered care from diagnosis through treatment, survivorship, or palliative stages. Key responsibilities include:

• Conducting detailed patient evaluations and obtaining relevant histories
• Encouraging patients to notice any unusual symptoms or changes and report them promptly
• Ordering and interpreting diagnostics (bone-marrow biopsies, flow cytometry, PET/CT, molecular panels), and recognizing signs in blood test results that may indicate blood disorders
• Explaining test results and diagnoses to patients to ensure they understand their condition and treatment options
• Designing individualized treatment plans including chemotherapy, targeted therapy, immunotherapy, transplantation, supportive care, and the use of medications as part of the treatment plan
• Beginning treatment promptly after diagnosis to manage blood-related conditions effectively
• Coordinating care with surgical, radiation, palliative, and allied health teams
• Monitoring response to therapy, managing side effects, and adjusting treatment regimens
• Providing survivorship care, monitoring for recurrence, and managing long-term complications
• Having a skilled hand in performing procedures, which is essential for accurate diagnosis and effective treatment

Given the complexity of hematologic and oncologic diseases, these physicians must deeply understand complex blood disorders for effective patient care. They frequently engage in multidisciplinary tumor boards, clinical trial enrollment decisions, and longitudinal patient management.

Demand for hematology-oncology expertise remains substantial, driven by the continued burden of cancer and hematologic disease, evolving treatment options, and regional workforce needs. Current federal projections anticipate a modest national shortfall in hematology-oncology physician supply through 2038.

Compensation in hematology-oncology varies by subspecialty, geography, practice setting, and procedural involvement. Hematology-oncology continues to offer diverse career opportunities across community practice, academic medicine, cancer centers, research programs, and specialized treatment centers.

Tangible Benefits:

• Competitive compensation with productivity and procedural incentives
• Comprehensive health, dental, and vision benefits; retirement plans
• Paid time off, CME support, signing bonuses, and relocation or loan-repayment programs in high-need regions
• Access to advanced treatments (CAR-T, immunotherapy) and research infrastructure

Intangible Benefits:

• Opportunity to impact patient outcomes in life-threatening disease
• Practice flexibility across inpatient, outpatient, academic, and research roles
• Collaborative work with multidisciplinary teams and subspecialists
• Career satisfaction from continuous innovation, teaching, and program leadership
• Hematologists are needed around the world, as blood disorders are a global concern and require international awareness and resources
• Hematologists handle a lot of cases and answer a lot of complex questions, demonstrating the breadth and depth of their expertise

Hematologist-oncologists often:

• Evaluate new patients and develop treatment strategies for blood disorders or cancers
• See patients who are referred for specialized care when blood-related symptoms or abnormal blood test results are detected
• Prescribe, manage, and monitor chemotherapy, immunotherapy, targeted therapy, and other systemic treatments, with transplant or cellular-therapy responsibilities depending on subspecialty practice
• Monitor treatment response, manage toxicities, and adjust therapy accordingly
• Coordinate multi-disciplinary care across tumor boards, transplant teams, and supportive services
• Work in research: enrolling patients in trials, analyzing outcomes, publishing results
• Teach medical trainees, lead quality-improvement initiatives, and contribute to program development

Hematology-oncology jobs are available in settings such as:

• Academic cancer centers and university hospitals
• Community hospitals with oncology services
• Outpatient infusion/clinic suites, comprehensive cancer centers
• Bone-marrow transplant units, cellular therapy clinics
• Research institutions and clinical-trial networks
• Tele-oncology platforms for outreach or remote care

Schedules vary by setting: inpatient transplant or hospital roles may involve on-call nights; outpatient clinics may follow weekday hours. Teamwork with advanced practice providers, pharmacists, infusion nurses, and research staff is common.

Becoming a hematologist-oncologist typically involves:

• Completing a bachelor’s degree with the required pre-medical coursework
• Attending medical school (MD or DO), which is required for all physicians
• Completing a residency in internal medicine (typically 3 years), as required for specialization
• Completion of a three-year accredited Hematology and Medical Oncology fellowship for physicians pursuing combined training; separate Hematology or Medical Oncology fellowship pathways generally require at least two years
• Completion of applicable medical licensing examinations, such as USMLE or COMLEX-USA, and fulfillment of state medical licensure requirement
• Board certification through ABIM in Hematology and Medical Oncology, as applicable to the physician's training and practice focus
• Ongoing continuing education and participation in applicable ABIM Maintenance of Certification requirements

Primary care physicians often refer patients to hematologists for further evaluation when abnormal blood test results or symptoms suggest a blood disorder.